LY4006896 / Eli Lilly - LARVOL DELTA

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease (clinicaltrials.gov) - P1 | N=127 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting | Trial completion date: May 2028 ➔ Nov 2027 | Trial primary completion date: May 2028 ➔ Nov 2027

Enrollment open • Trial completion date • Trial primary completion date • CNS Disorders • Movement Disorders • Parkinson's Disease